Literature DB >> 26168370

Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine Approach.

W Oliver Tobin1, Sean J Pittock2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26168370     DOI: 10.1001/jamaneurol.2015.1421

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  1 in total

1.  Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).

Authors:  Adi Vaknin-Dembinsky; Hanna Charbit; Livnat Brill; Oded Abramsky; Devorah Gur-Wahnon; Iddo Z Ben-Dov; Iris Lavon
Journal:  J Neuroinflammation       Date:  2016-07-08       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.